Objective To explore the potential diagnostic value of protocadherin 17(PCDH17)and transducer of ERBB2,(TOB1)in gastric cancer,as well as their effects on autophagy and apoptosis in gastric cancer cells,providing novel target insights for gastric canc-er diagnosis.Methods Tissue samples were collected from 120gastric cancer patients,including cancerous and adjacent normal tissues.The expression levels of PCDH17 and TOB1 were assessed via immunohistochemistry.Overexpression of PCDH17 and TOB1 in the AGS gastric cancer cell line was analyzed using real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)and Western blot.The effects of these overexpressions on cell proliferation,autophagy,and apoptosis were evaluated using CCK-8 assays,Western blot a-nalysis,and detection of autophagy and apoptosis-related proteins.Additionally,receiver operating characteristic(ROC)curve analysis was employed to evaluate the sensitivity and specificity of combined PCDH17 and TOB1 in diagnosing gastric cancer.Results The ex-pression levels of PCDH17 and TOB1 were significantly lower in gastric cancer tissues compared to adjacent normal tissues(P＜0.001),and their low expression was significantly correlated with clinical stage and lymph node metastasis(P＜0.001).In vitro experiments dem-onstrated that overexpression of PCDH17 and TOB1 could significantly inhibited the proliferation of gastric cancer cells(P＜0.001),and promoted autophagy and apoptosis through upregulation of autophagy markers LC3 and Beclin-1,along with pro-apoptotic protein BAX,while downregulating anti-apoptotic protein BCL-2.The combined overexpression of PCDH17 and TOB1 resulted in a more pronounced inhibitory effect on cell proliferation and enhanced levels of autophagy and apoptosis compared to individual overexpression(P＜0.001).The area under the curve for the combined diagnostic efficacy of PCDH17 and TOB1 was 0.887,with a sensitivity of 88.39％,and a spe-cificity of 87.24％,the diagnostic effect was superior to that of individual assays.Conclusion The low expression of PCDH17 and TOB1 is closely associated with the occurrence and progression of gastric cancer.Furthermore,the combined detection of these markers exhibits high sensitivity and specificity for gastric cancer diagnosis.The combined overexpression of PCDH17 and TOB1 had a significant synergistic effects on inhibiting proliferation while promoting autophagy and apoptosis of gastric cancer cells.PCDH17 and TOB1 can be used as po-tential diagnostic biomarkers and therapeutic targets for gastric cancer,providing new avenues for the diagnosis and targeted treatment of gastric cancer.

Objective To explore the potential diagnostic value of protocadherin 17(PCDH17)and transducer of ERBB2,(TOB1)in gastric cancer,as well as their effects on autophagy and apoptosis in gastric cancer cells,providing novel target insights for gastric canc-er diagnosis.Methods Tissue samples were collected from 120gastric cancer patients,including cancerous and adjacent normal tissues.The expression levels of PCDH17 and TOB1 were assessed via immunohistochemistry.Overexpression of PCDH17 and TOB1 in the AGS gastric cancer cell line was analyzed using real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)and Western blot.The effects of these overexpressions on cell proliferation,autophagy,and apoptosis were evaluated using CCK-8 assays,Western blot a-nalysis,and detection of autophagy and apoptosis-related proteins.Additionally,receiver operating characteristic(ROC)curve analysis was employed to evaluate the sensitivity and specificity of combined PCDH17 and TOB1 in diagnosing gastric cancer.Results The ex-pression levels of PCDH17 and TOB1 were significantly lower in gastric cancer tissues compared to adjacent normal tissues(P＜0.001),and their low expression was significantly correlated with clinical stage and lymph node metastasis(P＜0.001).In vitro experiments dem-onstrated that overexpression of PCDH17 and TOB1 could significantly inhibited the proliferation of gastric cancer cells(P＜0.001),and promoted autophagy and apoptosis through upregulation of autophagy markers LC3 and Beclin-1,along with pro-apoptotic protein BAX,while downregulating anti-apoptotic protein BCL-2.The combined overexpression of PCDH17 and TOB1 resulted in a more pronounced inhibitory effect on cell proliferation and enhanced levels of autophagy and apoptosis compared to individual overexpression(P＜0.001).The area under the curve for the combined diagnostic efficacy of PCDH17 and TOB1 was 0.887,with a sensitivity of 88.39％,and a spe-cificity of 87.24％,the diagnostic effect was superior to that of individual assays.Conclusion The low expression of PCDH17 and TOB1 is closely associated with the occurrence and progression of gastric cancer.Furthermore,the combined detection of these markers exhibits high sensitivity and specificity for gastric cancer diagnosis.The combined overexpression of PCDH17 and TOB1 had a significant synergistic effects on inhibiting proliferation while promoting autophagy and apoptosis of gastric cancer cells.PCDH17 and TOB1 can be used as po-tential diagnostic biomarkers and therapeutic targets for gastric cancer,providing new avenues for the diagnosis and targeted treatment of gastric cancer.